HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Helene Senellart Selected Research
Helene Senellart Research Topics
Disease
4
Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 05/2008
3
Neoplasms (Cancer)
05/2024 - 02/2015
2
Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2020
1
Ovarian Neoplasms (Ovarian Cancer)
05/2024
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020
1
Adenocarcinoma
12/2020
1
Sarcoma (Soft Tissue Sarcoma)
10/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1
Edema (Dropsy)
01/2020
1
Disease Progression
03/2012
Drug/Important Bio-Agent (IBA)
4
Irinotecan (Camptosar)
FDA Link
Generic
12/2020 - 03/2012
3
pembrolizumab
IBA
05/2024 - 12/2020
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
10/2020 - 05/2008
1
Platinum
IBA
05/2024
1
lenvatinib
IBA
05/2024
1
B7-H1 Antigen
IBA
01/2022
1
Docetaxel (Taxotere)
FDA Link
12/2020
1
Paclitaxel (Taxol)
FDA Link
Generic
12/2020
1
Panitumumab (Vectibix)
FDA Link
10/2020
1
tepotinib
IBA
01/2020
1
Cetuximab (Erbitux)
FDA Link
02/2015
1
Tyrosine Kinase Inhibitors
IBA
02/2015
1
pazopanib
FDA Link
02/2015
1
Bevacizumab (Avastin)
FDA Link
03/2012
1
XELOX
IBA
05/2008
1
Leucovorin (Folinic Acid)
FDA Link
05/2008
1
Fluorouracil (Carac)
FDA Link
Generic
05/2008
Therapy/Procedure
5
Therapeutics
05/2024 - 01/2020
5
Drug Therapy (Chemotherapy)
01/2022 - 05/2008